Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Gut microbial modulation of 3-hydroxyanthranilic acid and dopaminergic signalling influences attention in obesity

  • Castells-Nobau, Anna
  • Samulenaite, Solveiga
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
  • Mayneris Perxachs, Jordi
Background Obesity-related alterations in the gut microbiota have been linked to cognitive decline, yet their relationship with attention remains poorly understood. Objective To evaluate the possible relationships among gut metagenomics, plasma metabolomics and attention. Design We conducted faecal shotgun metagenomics and targeted plasma tryptophan metabolomics across three independent cohorts (n=156, n=124, n=804) with functional validations in preclinical models, including three faecal microbiota transplantation (FMT) experiments in mice and Drosophila melanogaster. Results Obesity was consistently associated with reduced attention. Metagenomics analyses identified Proteobacteria species and microbial functions related to tryptophan biosynthesis from anthranilic acid (AA) as negatively associated with attention in obesity. Plasma tryptophan metabolic profiling and machine learning revealed that 3-hydroxyanthranilic acid (3-HAA) was positively associated with attention, particularly in obesity, while AA showed a negative association. Bariatric surgery improved attention and enriched microbial species linked to attention. In mice, diet-induced obesity (DIO) and microbiota depletion reduced 3-HAA and 5-hydroxy-indole acetic acid (5-HIAA) concentrations in the prefrontal cortex (PFC), which were restored by FMT. Global metabolic profiling (>600 metabolites) of PFC from the FMT group identified 3-HAA and the tryptophan and tyrosine pathways among the most significant in mice receiving microbiota from high-attention donors. A second FMT experiment also revealed a consistent enrichment of the tryptophan and tyrosine metabolism at the transcriptional level in the PFC, with Haao (3-hydroxyantrhanilic acid dioxygenase) and Aox4 (aldehyde oxidase 4), key in 3-HAA and 5-HIAA degradation, among the significantly regulated genes. In a third FMT study, attentional traits were transmitted from humans to mice alongside modulation of serotonergic and dopaminergic pathways. In Drosophila, mono-colonisation with Enterobacter cloacae and DIO induced attention deficit-like behaviours, which were mitigated by 3-HAA supplementation. Conclusions We have identified the microbiota and 3-HAA as potential therapeutic targets to improve attention, especially in obesity., This work was partially supported by Instituto de Salud Carlos III through the projects PI20/01090 and PI23/00575 (co-funded by the European Union under the European Regional Development Fund. "A way to make Europe") to JM-P and PI21/01361 and PI24/00185 and ICREA-Acadèmia (#2021) to JMF-R, the project CNS2023-144218 funded by MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR to JM-P, and Generalitat de Catalunya 2021 SGR 01263. This work has also been co-financed by the Spanish Ministry of Science, Innovation and Universities with funds from the European Union NextGenerationEU, from the Recovery, Transformation and Resilience Plan (PRTR-C17.I1) and from the Autonomous Community of Catalonia within the framework of the Biotechnology Plan Applied to Health through the project PPCCADGUT to JM-P. AF is funded by the Horizon 2020 Framework Programme of the European Union under the Marie Sklodowska-Curie Innovative Training Network grant agreement No 859890. MA-R is funded by Instituto de Salud Carlos III (Madrid, Spain) through a predoctoral Río Hortega contract CM19/00190 (co-funded by European Regional Development Fund "Investing in your future"). AC-N is funded by Instituto de Salud Carlos III (Madrid, Spain) through the Miguel Servet Program CP24/00033 (co-funded by European Regional Development Fund "Investing in your future"). IDIBGI is a CERCA centre from the "CERCA Programme/Generalitat de Catalunya". This study was conducted using samples/data from the Healthy Imageomics Study, supported by the Specialization and Territorial Competitiveness Projects (PECT) within the RIS3Cat and the Catalonia ERDF Operational Programme 2014-2020. It was co-financed by the European Regional Development Fund (ERDF) of the European Union under the Catalonia ERDF Operational Programme 2014-2020 and by the Diputació de Girona. We want to particularly acknowledge the participants, to the IDIBGI Horizontal Aging Program and the IDIBGI Biobank (Biobanc IDIBGI, B.0000872), integrated in the Platform ISCIII Biomodels and Biobanks, for their collaboration. This work was also supported by Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación (AEI) (PID2020- 120029GB-I00/MICIN/AEI/ 10.13039/501100011033, RD21/0009/0019 and PDI20231511680B-C21), the Spanish "Instituto de Salud Carlos III, RETICSRTA" (#RD12/0028/0023), the "Generalitat de Catalunya, AGAUR" (#2017 SGR-669), "ICREA-Acadèmia" (#2015) and the Spanish "Ministerio de Sanidad, Servicios Sociales e Igualdad", "Plan Nacional Sobre Drogas of the Spanish Ministry of Health" (#PNSD-2017I068) to RM, la Caixa Health" LCR/PR/HR22/5240017 to RM and EM-G, "Plan Nacional Sobre Drogas of the Spanish Ministry of Health" (#PNSD2019I006, #PNSD-2023I040) and Spanish "Ministerio de Ciencia e Innovación" (ERA-NET) PCI2021-122073-2A to EM-G.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Gut microbiota signatures of vulnerability to food addiction in mice and humans

  • Samulėnaitė, Solveiga
  • García-Blanco, Alejandra
  • Mayneris-Perxachs, Jordi
  • Domingo-Rodríguez, Laura
  • Cabana-Domínguez, Judit
  • Fernàndez-Castillo, Noèlia
  • Gago-García, Edurne
  • Pineda-Cirera, Laura
  • Burokas, Aurelijus
  • Espinosa-Carrasco, Jose
  • Arboleya, Silvia
  • Latorre, Jessica
  • Stanton, Catherine
  • Hosomi, Koji
  • Kunisawa, Jun
  • Cormand, Bru
  • Fernández-Real, Jose Manuel
  • Maldonado, Rafael
  • Martín-García, Elena
Food addiction is a multifactorial disorder characterised by a loss of control over food intake that may promote obesity and alter gut microbiota composition. We have investigated the potential involvement of the gut microbiota in the mechanisms underlying food addiction., This work was supported by La Caixa Health #LCF/PR/HR22/52420017, the Spanish ’Ministerio de Ciencia, Innovación y Universidades (MICIU), Agencia Estatal de Investigación (AEI)’ (PID2020- 120029GB-I00/ MICIU/ AEI/10.13039/501100011033, RD21/0009/0019), the Spanish ’Instituto de Salud Carlos III, RETICS-RTA’ (#RD12/0028/0023), the ’Generalitat de Catalunya, AGAUR’ (#2017 SGR-669), ’La Marató de TV3’ #20221830, ’ICREA-Acadèmia’ (#2015) and the Spanish ’Ministerio de Sanidad, Servicios Sociales e Igualdad, ’Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2017I068) to RM, ’Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2019I006, #PNSD-2023I040) and Spanish Ministerio de Ciencia e Innovación (ERA-NET) PCI2021-122073- 2A to EM-G. Spanish-MINECO (#SAF2017-84060- R- AEI/ FEDER-UE) to LD-R, Spanish ’Ministerio de Ciencia, Innovación y Universidades’ (#RTI2018-100968- B- 100, #PID2021-127776OB- I00), ’AGAUR-Generalitat de Catalunya’ (#2017-SGR- 738, #2021-SGR- 01093) and Spanish ’Ministerio de Sanidad, Servicios Sociales e Igualdad, ’Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2017I050) to BC, ’Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2020I042) to NF-C and the European Regional Development Fund (project No 01.2.2-LMT- K- 718- 03- 0099) under grant agreement with the Research Council of Lithuania (LMTLT) to AB. The research leading to these results has also received funding from the European Union H2020 Program [H2020/2014-2020] under grant agreements Nos 667302 (CoCA), 643051 (MiND) and 728018 (Eat2beNICE), ’La Marató de TV3’ #20221831 and from the Catalan Government (ICREA Academia Award 2021) to BC. JC-D was supported by the H2020 CoCA and Eat2beNICE projects and EG-G by projects of the Spanish Ministries (#PNSD-2020I042 and #PID2021-127776OB- I00). This work was partially supported by Instituto de Salud Carlos III through the projects PI20/01090 and PI23/00575 to JM-P and PI18/01022 and PI21/01361 to JMF-R (co-funded by European Regional Development Fund. “A way to make Europe”). It was also supported through the project CNS2023-144218 funded by MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR to JM-P. The work has also received funding from ”la Caixa” Foundation under the grant agreement LCF/PR/HR22/52420017 and support from Generalitat de Catalunya (ICREA Academia Award 2021 and 2021 SGR 01263) to JMF-R. IDIBGI is a CERCA centre from the ’CERCA Programme/Generalitat de Catalunya’., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Metformin-induced changes in the gut microbiome and plasma metabolome are associated with cognition in men

  • Rosell-Díaz, Marisel
  • Petit-Gay, Anna
  • Molas-Prat, Clàudia
  • Gallardo-Nuell, Laura
  • Ramió-Torrentà, Lluís
  • Garre-Olmo, Josep
  • Pérez-Brocal, Vicente
  • Moya, Andrés
  • Jové, Mariona
  • Pamplona, Reinald
  • Puig, Josep
  • Ramos, Rafael
  • Bäckhed, Fredrik
  • Mayneris-Perxachs, Jordi
  • Fernández-Real, José Manuel
[Background]: An altered gut microbiome characterized by reduced abundance of butyrate producing bacteria and reduced gene richness is associated with type 2 diabetes (T2D). An important complication of T2D is increased risk of cognitive impairment and dementia. The biguanide metformin is a commonly prescribed medication for the control of T2D and metformin treatment has been associated with a significant reduction in the risk of dementia and improved cognition, particularly in people with T2D., [Aim]: To investigate the associations of metformin use with cognition exploring potential mechanisms by analyzing the gut microbiome and plasma metabolome using shotgun metagenomics and HPLC-ESI-MS/MS, respectively., [Methods]: We explored two independent cohorts: an observational study (Aging Imageomics) and a phase IV, randomized, double-blind, parallel-group, randomized pilot study (MEIFLO). From the two studies, we analyzed four study groups: (1) individuals with no documented medical history or medical treatment (n = 172); (2) people with long-term T2D on metformin monotherapy (n = 134); (3) people with long-term T2D treated with oral hypoglycemic agents other than metformin (n = 45); (4) a newly diagnosed T2D subjects on metformin monotherapy (n = 22). Analyses were also performed stratifying by sex., [Results]: Several bacterial species belonging to the Proteobacteria (Escherichia coli) and Verrucomicrobia (Akkermansia muciniphila) phyla were positively associated with metformin treatment, while bacterial species belonging to the Firmicutes phylum (Romboutsia timonensis, Romboutsia ilealis) were negatively associated. Due to the consistent increase in A. muciniphila and decrease in R.ilealis in people with T2D subjects treated with metformin, we investigated the association between this ratio and cognition. In the entire cohort of metformin-treated T2D subjects, the A.muciniphila/R.ilealis ratio was not significantly associated with cognitive test scores. However, after stratifying by sex, the A.muciniphila/R. ilealis ratio was significantly and positively associated with higher memory scores and improved memory in men. Metformin treatment was associated with an enrichment of microbial pathways involved in the TCA cycle, and butanoate, arginine, and proline metabolism in both cohorts. The bacterial genes involved in arginine metabolism, especially in production of glutamate (astA, astB, astC, astD, astE, putA), were enriched following metformin intake. In agreement, in the metabolomics analysis, metformin treatment was strongly associated with the amino acid proline, a metabolite involved in the metabolism of glutamate., [Conclusions]: The beneficial effects of metformin may be mediated by changes in the composition of the gut microbiota and microbial-host-derived co-metabolites., This work was partially funded by Instituto de Salud Carlos III (ISCIII, Madrid, Spain) through the projects PI15/01934 and PI21/01361 to J.M.F-R and the project PI20/01090 and PI23/00575 (co-funded by the European Union under the European Regional Development Fund (FEDER) “A way to make Europe”) to J.M-P. Generalitat de Catalunya (2021 SGR 01263). M.R.D. is funded by Girona Biomedical Research Institute (Girona, Spain) through the Horizon 2020 Framework Programme of the European Union under the Marie Skłodowska-Curie Innovative Training Network grant agreement No 859890. The Aging Imageomics Study has been funded by Pla estratègic de recerca i innovació en salut 2016-2020 from Generalitat de Catalunya (reference number, SLT002/16/00250). IRBLleida is a CERCA Programme of the Government of Catalonia. IDIBGI is a CERCA Programme/Generalitat de Catalunya. M.J. is a ‘Serra-Hunter’ Fellow. J.M.-P. is funded by Instituto de Salud Carlos III (Madrid, Spain) through the Miguel Servet Program CP18/00009 (co-funded by European Union under the European Social Fund “Investing in your future”). J.M.-P. was also supported through the project CNS2023-144218 funded by MICIU/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR., Open Access funding provided by the CRUE-CSIC agreement with Elsevier., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Archaea methanogens are associated with cognitive performance through the shaping of gut microbiota, butyrate and histidine metabolism

  • Fumagalli, Andrea
  • Castells-Nobau, Anna
  • Trivedi, Dakshat
  • Garre-Olmo, Josep
  • Puig, Josep
  • Ramos, Rafel
  • Ramió-Torrentà, Lluís
  • Pérez-Brocal, Vicente
  • Moya, Andrés
  • Swann, Jonathan
  • Martin-Garcia, Elena
  • Maldonado, Rafael
  • Fernández-Real, José Manuel
The relationship between bacteria, cognitive function and obesity is well established, yet the role of archaeal species remains underexplored. We used shotgun metagenomics and neuropsychological tests to identify microbial species associated with cognition in a discovery cohort (IRONMET, n = 125). Interestingly, methanogen archaeas exhibited the strongest positive associations with cognition, particularly Methanobrevibacter smithii (M. smithii). Stratifying individuals by median-centered log ratios (CLR) of M. smithii (low and high M. smithii groups: LMs and HMs) revealed that HMs exhibited better cognition and distinct gut bacterial profiles (PERMANOVA p = 0.001), characterized by increased levels of Verrucomicrobia, Synergistetes and Lentisphaerae species and reduced levels of Bacteroidetes and Proteobacteria. Several of these species were linked to the cognitive test scores. These findings were replicated in a large-scale validation cohort (Aging Imageomics, n = 942). Functional analyses revealed an enrichment of energy, butyrate, and bile acid metabolism in HMs in both cohorts. Global plasma metabolomics by CIL LC-MS in IRONMET identified an enrichment of methylhistidine, phenylacetate, alpha-linolenic and linoleic acid, and secondary bile acid metabolism associated with increased levels of 3-methylhistidine, phenylacetylgluamine, adrenic acid, and isolithocholic acid in the HMs group. Phenylacetate and linoleic acid metabolism also emerged in the Aging Imageomics cohort performing untargeted HPLC-ESI-MS/MS metabolic profiling, while a targeted bile acid profiling identified again isolithocholic acid as one of the most significant bile acid increased in the HMs. 3-Methylhistidine levels were also associated with intense physical activity in a second validation cohort (IRONMET-CGM, n = 116). Finally, FMT from HMs donors improved cognitive flexibility, reduced weight, and altered SCFAs, histidine-, linoleic acid- and phenylalanine-related metabolites in the dorsal striatum of recipient mice. M. smithii seems to interact with the bacterial ecosystem affecting butyrate, histidine, phenylalanine, and linoleic acid metabolism with a positive impact on cognition, constituting a promising therapeutic target to enhance cognitive performance, especially in subjects with obesity., (ISCIII, Madrid, Spain) through the projects PI15/01934, PI18/01022 and PI21/01361 to J.M.F-R and the project PI20/01090 and PI23/00575 (co-funded by the European Union under the European Regional Development Fund (FEDER) “A way to make Europe”) to J.M-P, the project CNS2023-144218 funded by MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR to J.M-P, and (2021 SGR 01263). This work has also been co-financed by the Spanish Ministry of Science, Innovation and Universities with funds from the European Union NextGenerationEU, from the Recovery, Transformation and Resilience Plan (PRTR-C17.I1) and from the Autonomous Community of Catalonia within the framework of the Biotechnology Plan Applied to Health through the project PPCC-ADGUT to J.M.-P. J.M-P and A.C.N are funded by (Madrid, Spain) through the Miguel Servet Program CP18/00009 and CP24/00033 (co-funded by the European Union under the European Social Fund “Investing in your future”), respectively. A.F. is funded by Girona Biomedical Research Institute (Girona, Spain) through the Horizon 2020 Framework Programme of the European Union under the Marie Skłodowska-Curie Innovative Training Network grant agreement No 859890. This study was conducted using samples/data from the Aging Imageomics Study, supported by the through the Strategic Plan for Health Research and Innovation (PERIS) 2016–2020 (SLT002/16/00250). We want to particularly acknowledge the participants, to the IDIBGI Horizontal Aging Program and the IDIBGI Biobank (Biobanc IDIBGI, B.0000872), integrated in the Platform ISCIII Biomodels and Biobanks, for their collaboration. JRS is supported by the NIHR Southampton Biomedical Research Centre, and the Biotechnology and Biological Sciences Research Council (BB/W00139X/1)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Glucose metabolism's impact on Blastocystis presence in the human gut

  • Paulí, Sara
  • Rosell-Díaz, Marisel
  • Moreno-Navarrete, José Maria
  • Pons Tamarit, Javier
  • Pérez-Brocal, Vicente
  • Moya, Andrés
  • Puig, Josep
  • Garre-Olmo, Josep
  • Ramos, Rafael
  • Fernández-Real, José Manuel
  • Mayneris-Perxachs, Jordi
[Availability of data and materials] Data will be available upon personal request. The raw metagenomics sequence data derived from human samples in the IRONMET-CGM, Aging Imageomics, Healthy Imageomics and MEIFLO cohorts have been deposited in the European Nucleotide Archive (ENA) under the projects numbers PRJEB58106, PRJEB52682, PRJEB61680 and PRJNA361402, respectively., [Background and Aims]: The role of Blastocystis spp. parasite in human health remains debated. Recent literature associates it with a healthy gut and lifestyle. Evidence suggests that Blastocystis spp. could enhance glucose homeostasis, although Blastocystis spp. is considered to be epiphenomena for a lifestyle. Moreover, some subtypes seem to have a beneficial impact while others would hinder the host's health. Here, we explore the complex link between Blastocystis spp. and glucose metabolism parameters., [Methods]: We explored shotgun metagenomic profiles of the gut microbiota from fecal samples associated with glucose metabolism parameters in 4 independent cohorts (CGM, n = 65; IMAGEOMICS, n = 1030; PECT, n = 841 and MEIFLO, n = 22), using microbiome compositional analysis methodology. We leverage data from MEIFLO, a recent clinical trial conducted in patients recently diagnosed with type 2 diabetes (T2D), to investigate how metformin-induced improvement in glucose metabolism influences gut microbiota composition, using Linear Models for Differential Abundance. We studied possible associations of Blastocystis spp. with leukocyte telomere length., [Results]: We confirmed and extended the relationship between glucose homeostasis and Blastocystis spp. and subtypes ST1 and ST4, showing its association with glucose and insulin levels in all cohorts. Importantly, we observed that glucose homeostasis may shape Blastocystis spp. abundance in the gut, rather than the reverse, based on clinical trial data showing that metformin (not placebo) increased Blastocystis spp. in recently diagnosed T2D patients. We identify Blastocystis as one of the microbial genera most strongly and directly associated with telomere length in the IMAGEOMICS cohort., [Conclusions]: The direct relation between Blastocystis and telomere length aligns with the observed inverse associations of glucose levels with telomere length, and glucose levels with Blastocystis. We propose that Blastocystis may be associated with healthy glucose metabolism as an outcome and potentially serve as an indicator of improved metabolic health., This work was partially funded by Instituto de Salud Carlos III (ISCIII, Madrid, Spain) through the projects PI15/01934, PI18/01022, PI21/01361 and PMP21/00072 (co-funded by the European Union/Plan de Recuperación, Transformación y Resiliencia) to JMF-R and the projects PI20/01090 and PI23/00575 (co-funded by the European Union under the European Regional Development Fund (FEDER). “A way to make Europe”) to JM-P, the project CNS2023-144218 funded by MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR to JM-P, and Generalitat de Catalunya 2021 SGR 01263. This work has also been co-financed by the Spanish Ministry of Science, Innovation and Universities with funds from the European Union NextGenerationEU, from the Recovery, Transformation and Resilience Plan (PRTR-C17.I1) and from the Autonomous Community of Catalonia within the framework of the Biotechnology Plan Applied to Health through the project PPCC-ADGUT to JM-P. IDIBGI is a CERCA centre from the “CERCA Programme/Generalitat de Catalunya”. This study was conducted using samples/data from the Aging Imageomics Study, supported by the Generalitat de Catalunya through the Strategic Plan for Health Research and Innovation (PERIS) 2016–2020 (SLT002/16/00250). This study was also conducted using samples/data from the Healthy Imageomics Study, supported by the Specialization and Territorial Competitiveness Projects (PECT) within the RIS3Cat and the Catalonia ERDF Operational Programme 2014–2020. It was co-financed by the European Regional Development Fund (ERDF) of the European Union under the Catalonia ERDF Operational Programme 2014–2020 and by the Diputació de Girona. We want to particularly acknowledge the participants, to the IDIBGI Horizontal Aging Program and the IDIBGI Biobank (Biobanc IDIBGI, B.0000872), integrated in the Platform ISCIII Biomodels and Biobanks, for their collaboration., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Ecological restructuring of the nonbacterial fecal microbiome in obesity across human cohorts

  • Gallardo-Nuell, Laura
  • Rosell-Díaz, Marisel
  • Garre-Olmo, Josep
  • Puig, Josep
  • Ramos, Rafael
  • Pons Tamarit, Javier
  • Pérez-Brocal, Vicente
  • Moya, Andrés
  • Mayneris-Perxachs, Jordi
  • Fernández-Real, José Manuel
Obesity is a complex metabolic disorder increasingly linked to alterations in the gut microbiome. While most research has focused on bacterial communities, the contribution of nonbacterial components including viruses, archaea, and eukaryotic microorganisms remains insufficiently characterized. Here, we performed a multicohort analysis to investigate the role of the nonbacterial gut microbiome in obesity across three independent human cohorts. Using compositional analyses adjusted for key covariates and network based approaches, we identified consistent multikingdom alterations associated with obesity. Individuals without obesity showed a reproducible enrichment of methanogenic archaea, particularly Methanobrevibacter smithii and Methanobrevibacter millerae, whereas individuals with obesity were characterized by increased abundance of bacteriophages from the class Caudoviricetes. In an elderly cohort, eukaryotic taxa such as Blastocystis spp. were additionally associated with the without obesity group. These patterns were largely consistent across cohorts and robust to sex stratification. Beyond taxonomic differences, ecological network analyses revealed substantial reorganization of microbial interactions in obesity. The identity and composition of hub taxa differed significantly between obesity and without obesity networks across all cohorts, indicating a shift in the taxa occupying central ecological roles. Notably, these differences were observed even when similar microbial kingdoms were represented, underscoring the importance of species-level resolution. Collectively, our findings demonstrate that obesity is associated with coordinated compositional and ecological alterations across the nonbacterial gut microbiome. This multikingdom perspective expands current understanding of microbiome dysbiosis in metabolic disease and highlights the archaeome and virome as potential contributors to host metabolic health., This work was partially supported by Instituto de Salud Carlos III through the projects PI20/01090 (co-funded by European Regional Development Fund. ‘A way to make Europe) and PI23/00575 (co-funded by the European Union) to JM-P, PMP21/00072 (European Union NextGenerationEU/PRTR) and PI21/01361 and PI24/00185 (co-funded by the European Union) to JMF-R, and FI24/00032 co-funded by the European Union to LG-N. It was also partially funded through ICREA-Acadèmia” (#2021) to JMF-R and the project CNS2023-144218 funded by MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR to JM-P, and Generalitat de Catalunya 2021 SGR 01263. This study was partially conducted using samples/data from the Aging Imageomics Study, supported by the Generalitat de Catalunya through the Strategic Plan for Health Research and Innovation (PERIS) 2016-2020 (SLT002/16/00250). We want to particularly acknowledge the participants, to the IDIBGI Horizontal Aging Program and the IDIBGI Biobank (B.0000872), integrated in the Platform ISCIII Biomodels and Biobanks, for their collaboration. IDIBGI is a CERCA center from the “CERCA Program/Generalitat de Catalunya”. The project that gave rise to these results has received funding from ”la Caixa” Foundation under the grant agreement LCF/PR/HR22/52420017., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Sex-specific microbial and tryptophan signatures of depression implicate archaeal methanogens and indole-3-acetic acid only in women

  • Motger-Albertí, Anna
  • Gallardo-Nuell, Laura
  • Rosell-Díaz, Marisel
  • Stefoglo, Mihaela
  • Pons Tamarit, Javier
  • Garre-Olmo, Josep
  • Pérez-Brocal, Vicente
  • Moya, Andrés
  • Puig, Josep
  • Ramos, Rafael
  • Mayneris-Perxachs, Jordi
  • Fernández-Real, José Manuel
[Data availability] Samples and data from participants included in this study were provided by the IDIBGI Horizontal Aging Program and the IDIBGI Biobank from the Healthy Imageomics Study. They were processed following standard operating procedures with the appropriate approval of the Ethics and Scientific Committees. The Healthy Imageomics Study is an observational study including participants of the province of Girona (Northeast Catalonia, Spain). Detailed description of the cohort can be found (https://gironasalutlivinglab.idibgi.org/). The datasets that support the findings of the study are available from the corresponding author upon reasonable request. The raw metagenomics sequence data derived from human samples in the Health Imageomics cohorts have been deposited in the European Nucleotide Archive (ENA) under the project number PRJEB104636 ., Sex differences in mental health are often overlooked, yet gut microbiota–host metabolite interactions may contribute to sexual dimorphism in depression. In a population-based cohort, we investigated sex-specific links among plasma tryptophan metabolites, depressive symptoms (PHQ-9), and the gut microbiome, controlling for smoking, diet, alcohol, and physical activity. Women (N = 419) exhibited higher plasma indole-3-acetic acid (IAA) and picolinic acid (PA) concentrations, but lower trigonelline (TRIG) than men (N = 383). Machine learning models with SHAP explanations revealed that IAA and TRIG were positively associated, whereas PA was negatively associated with depression severity in women, whereas only kynurenic acid (KA) was inversely associated in men. In women, depression severity strongly correlated with methanogenic archaea, including Methanobrevibacter smithii, and microbial methane-production pathways. Methanobrevibacter and specifically M. smithii were negatively linked to genes for tryptophan, PA, and KA biosynthesis, but positively to genes for IAA and nicotinate/nicotinamide metabolism. Most microbial species associated with depression severity in women were predicted to produce IAA. These findings reveal pronounced sex-specific microbiome–metabolite interactions, highlighting potentially distinct microbial mechanisms shaping depression in men and women., This work was partially funded by Instituto de Salud Carlos III (ISCIII, Madrid, Spain) through the projects PI15/01934, PI24/00185, PI21/01361 and PI18/01022 to J.M.F-R and the projects PI20/01090 and PI23/00575 (co-funded by the European Union under the European Regional Development Fund (FEDER). “A way to make Europe”) to J.M-P, the project CNS2023-144218 funded by MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR to J.M-P, and Generalitat de Catalunya 2021 SGR 01263. This work has also been co-financed by the Spanish Ministry of Science, Innovation and Universities with funds from the European Union NextGenerationEU, from the Recovery, Transformation and Resilience Plan (PRTR-C17.I1) and from the Autonomous Community of Catalonia within the framework of the Biotechnology Plan Applied to Health through the project PPCC-ADGUT to JM-P. This study was conducted using samples/data from the Healthy Imageomics Study, supported by the Specialization and Territorial Competitiveness Projects (PECT) within the RIS3Cat and the Catalonia ERDF Operational Programme 2014-2020. It was co-financed by the European Regional Development Fund (ERDF) of the European Union under the Catalonia ERDF Operational Programme 2014-2020 and by the Diputació de Girona. IDIBGI is a CERCA Programme/Generalitat de Catalunya. We want to particularly acknowledge the participants, to the Healthy Imageomics Study, the IDIBGI Horizontal Aging Program and the IDIBGI Biobank (Biobanc IDIBGI, B.0000872), integrated in the Platform ISCIII Biomodels and Biobanks, for their collaboration., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Gut microbial modulation of 3-hydroxyanthranilic acid and dopaminergic signalling influences attention in obesity

  • Castells-Nobau, Anna
  • Samulenaite, Solveiga
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
  • Mayneris Perxachs, Jordi
Background Obesity-related alterations in the gut microbiota have been linked to cognitive decline, yet their relationship with attention remains poorly understood. Objective To evaluate the possible relationships among gut metagenomics, plasma metabolomics and attention. Design We conducted faecal shotgun metagenomics and targeted plasma tryptophan metabolomics across three independent cohorts (n=156, n=124, n=804) with functional validations in preclinical models, including three faecal microbiota transplantation (FMT) experiments in mice and Drosophila melanogaster. Results Obesity was consistently associated with reduced attention. Metagenomics analyses identified Proteobacteria species and microbial functions related to tryptophan biosynthesis from anthranilic acid (AA) as negatively associated with attention in obesity. Plasma tryptophan metabolic profiling and machine learning revealed that 3-hydroxyanthranilic acid (3-HAA) was positively associated with attention, particularly in obesity, while AA showed a negative association. Bariatric surgery improved attention and enriched microbial species linked to attention. In mice, diet-induced obesity (DIO) and microbiota depletion reduced 3-HAA and 5-hydroxy-indole acetic acid (5-HIAA) concentrations in the prefrontal cortex (PFC), which were restored by FMT. Global metabolic profiling (>600 metabolites) of PFC from the FMT group identified 3-HAA and the tryptophan and tyrosine pathways among the most significant in mice receiving microbiota from high-attention donors. A second FMT experiment also revealed a consistent enrichment of the tryptophan and tyrosine metabolism at the transcriptional level in the PFC, with Haao (3-hydroxyantrhanilic acid dioxygenase) and Aox4 (aldehyde oxidase 4), key in 3-HAA and 5-HIAA degradation, among the significantly regulated genes. In a third FMT study, attentional traits were transmitted from humans to mice alongside modulation of serotonergic and dopaminergic pathways. In Drosophila, mono-colonisation with Enterobacter cloacae and DIO induced attention deficit-like behaviours, which were mitigated by 3-HAA supplementation. Conclusions We have identified the microbiota and 3-HAA as potential therapeutic targets to improve attention, especially in obesity., This work was partially supported by Instituto de Salud Carlos III through the projects PI20/01090 and PI23/00575 (co-funded by the European Union under the European Regional Development Fund. "A way to make Europe") to JM-P and PI21/01361 and PI24/00185 and ICREA-Acadèmia (#2021) to JMF-R, the project CNS2023-144218 funded by MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR to JM-P, and Generalitat de Catalunya 2021 SGR 01263. This work has also been co-financed by the Spanish Ministry of Science, Innovation and Universities with funds from the European Union NextGenerationEU, from the Recovery, Transformation and Resilience Plan (PRTR-C17.I1) and from the Autonomous Community of Catalonia within the framework of the Biotechnology Plan Applied to Health through the project PPCCADGUT to JM-P. AF is funded by the Horizon 2020 Framework Programme of the European Union under the Marie Sklodowska-Curie Innovative Training Network grant agreement No 859890. MA-R is funded by Instituto de Salud Carlos III (Madrid, Spain) through a predoctoral Río Hortega contract CM19/00190 (co-funded by European Regional Development Fund "Investing in your future"). AC-N is funded by Instituto de Salud Carlos III (Madrid, Spain) through the Miguel Servet Program CP24/00033 (co-funded by European Regional Development Fund "Investing in your future"). IDIBGI is a CERCA centre from the "CERCA Programme/Generalitat de Catalunya". This study was conducted using samples/data from the Healthy Imageomics Study, supported by the Specialization and Territorial Competitiveness Projects (PECT) within the RIS3Cat and the Catalonia ERDF Operational Programme 2014-2020. It was co-financed by the European Regional Development Fund (ERDF) of the European Union under the Catalonia ERDF Operational Programme 2014-2020 and by the Diputació de Girona. We want to particularly acknowledge the participants, to the IDIBGI Horizontal Aging Program and the IDIBGI Biobank (Biobanc IDIBGI, B.0000872), integrated in the Platform ISCIII Biomodels and Biobanks, for their collaboration. This work was also supported by Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación (AEI) (PID2020- 120029GB-I00/MICIN/AEI/ 10.13039/501100011033, RD21/0009/0019 and PDI20231511680B-C21), the Spanish "Instituto de Salud Carlos III, RETICSRTA" (#RD12/0028/0023), the "Generalitat de Catalunya, AGAUR" (#2017 SGR-669), "ICREA-Acadèmia" (#2015) and the Spanish "Ministerio de Sanidad, Servicios Sociales e Igualdad", "Plan Nacional Sobre Drogas of the Spanish Ministry of Health" (#PNSD-2017I068) to RM, la Caixa Health" LCR/PR/HR22/5240017 to RM and EM-G, "Plan Nacional Sobre Drogas of the Spanish Ministry of Health" (#PNSD2019I006, #PNSD-2023I040) and Spanish "Ministerio de Ciencia e Innovación" (ERA-NET) PCI2021-122073-2A to EM-G.